Polygenic Risk Map – Male Complete

What this laboratory test evaluates

Boston Heart’s Polygenic Risk Map test is a genetic test that leverages Polygenic Risk Score (PRS) analysis and reporting. The resulting risk scores provide clinical insights into a variety of important health conditions.

Clinical utility of the Polygenic Risk MapRisk scores are determined by numerous well-studied genetic variations and allow for impactful and targeted application of genomic testing to personalized medicine.

High-risk individuals generally have a substantially increased relative genetic risk for these conditions as compared to low-risk subjects.

Because the lifetime risk of these conditions is also substantially influenced by environment, lifestyle, and medical care, a greater understanding of genetic risks may lead to greater preventive efforts.

Cost-effectiveness studies suggest that providers can reduce cardiovascular events and healthcare system costs by using polygenic risk scores in appropriate patients.
This type of testing is meant to augment rather than replace standard risk factor assessments for cardiovascular disease, breast cancer, prostate cancer, or other conditions.

Risk scores provide the lifetime risk of developing the condition of interest.

Analysis included in the Male Complete Polygenic Risk Map:
CAD
Stroke
Atrial Fibrillation
Type 2 Diabetes
Hypertension
BMI
Polygenic Hypercholesterolemia Lipoprotein (a)
Triglycerides
Hypo-HDL Cholesterolemia
Alzheimer's Disease
Brain Cancer
Pancreatic Cancer
Kidney Cancer
Melanoma
Inflammatory Bowel Disease
Psoriasis
Celiac Disease
Ancestry

Additional test information

The Polygenic Risk Map test is a genetic test that leverages Polygenic Risk Score (PRS) analysis and reporting to evaluate the risk of hypertension, cardiovascular disease, dementia, diabetes, and prostate, pancreatic, colon, and brain cancers in male patients. The client’s results are compared to the European data bank of known diseases in which the genetic similarities have been defined.

Collection and processing

• Sample type: Saliva
• Fasting: No
• Estimated laboratory processing: Results should arrive 30 business days after the lab receives samples.

How Sunridge uses laboratory information

Sunridge considers the medical question, symptoms, history, medications, prior results, and whether the finding could change care before recommending testing. A laboratory result is not interpreted in isolation and does not establish a diagnosis by itself.

Before requesting this test

Availability, collection requirements, eligibility, and processing estimates can change. Sunridge reviews each request and, when appropriate, creates the order through Fullscript. Follow the current instructions supplied with the approved order.